Clinical Trial Detail

NCT ID NCT01887717
Title Efficacy Evaluation of TheraSphere to Treat Inoperable Liver Cancer With Blockage of the Portal Vein
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements No
Sponsors BTG International Inc.
Indications

hepatocellular carcinoma

Therapies

Sorafenib

Age Groups: adult

No variant requirements are available.